Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Outside the Lab Informatics, Personalized medicine, Professional development

Asking the Ultimate Question

Over the last 30 years, I’ve watched biomedical research rapidly embrace new technologies aimed at developing better drugs and improving patient care and outcome. This evolution extends from molecular modeling to bioinformatics, translational medicine, and now the conversion of personalized medicine into precision medicine and its enhancement with big data. Although these approaches typically develop from academic research, they have all migrated to commercial activities (and investment opportunities), while promising to improve healthcare.

In many cases, approaches have evolved from breakthrough science to commoditization and integration into standard research practice. For example, molecular modeling progressed from computational/quantum evaluation of chemical properties to visualization/graphics and molecular dynamics. Now, no drug is developed that does not use some form of this analysis. Bioinformatics evolved from protein structure–function analysis to sequence analysis of proteins, nucleic acids and genomes. Molecular biologists now routinely apply complex algorithms developed in advanced research in disparate areas.

Read the full article now

Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Michael N. Liebman

Michael Liebman has more than 40 years of experience split between academics and industry, having traversed that “chasm of culture” several times with a stop along the way to lead a US Department of Defence-sponsored research institute. His career has taken him from starting at the (sub)-molecular level to today, where he focuses on real-world medicine and patients, developing and implementing methods for quantitative and qualitative analysis. Michael applies system-based approaches to define the full complexity of the problem. His approach to modelling applies design thinking and is complementary to the more traditional methods of statistical analysis and data mining.

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Related Articles

Tools & Techniques Imaging

Revamping the Digital Interface

| Luke Turner

Tools & Techniques Imaging

IVF ID

| Jonathan James

Tools & Techniques Informatics

RePURPOSED

| Maryam Mahdi

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register